# US 2023/0407411 A1 · Method for producing complex, method for determining microbial inclusion, and method for identifying included microorganism

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0407411 A1
- Document ID: US20230407411A1
- Status: Published application
- Kind: A1
- Application number: 18/192,147
- Filed: 2023-03-29
- Published: 2023-12-21
- Earliest claimed: 2022-03-29
- Assignees: Yokogawa Electric Corporation
- Applicants: Yokogawa Electric Corporation
- Inventors: Takashi Tadenuma; Yuki Miyauchi; Tomoyuki Taguchi; Takeo Tanaami
- Web page: https://patentgrep.com/patent/US20230407411A1

## CPC

- C12Q 1/682: Signal amplification
- C12Q 1/689: for bacteria
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method for producing a complex, a method for determining microbial inclusion, and a method for identifying the included microorganism, which can be easily performed is provided. A method for producing a complex containing a target that is contained in a sample, includes a step (a) of bringing a sample into contact with a label molecule A, a label molecule B, and a label molecule C and forming a complex, and a step (b) of isolating the complex. The target is a nucleic acid. The label molecule A contains a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target. The label molecule B contains a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target.

## Claims

### Claim 1

A method for producing a complex comprising a target that is contained in a sample comprising:
a step (a) of bringing a sample containing a target into contact with a label molecule A, a label molecule B, and a label molecule C and forming the complex comprising the target, the label molecule A, the label molecule B, and the label molecule C; and
a step (b) of isolating the complex,
wherein
the target is a nucleic acid,
the label molecule A comprises a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to a nucleic acid sequence of the target,
the label molecule B comprises the nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target,
a substantially complementary nucleic acid sequence of the label molecule A is capable of hybridizing to a part of the target and a substantially complementary nucleic acid sequence of the label molecule B is capable of hybridizing to another part of the target,
the label molecule C comprises a nucleic acid sequence capable of hybridizing to a part of the label molecule A and substantially complementary to the nucleic acid sequence of the label molecule A, and
at least one of either the label molecule A or the label molecule C has a phosphor.

### Claim 2 (depends on 1)

The method for producing a complex according to claim 1, wherein the label molecule B has at least one of either magnetic microparticles or metal microparticles.

### Claim 3 (depends on 1)

The method for producing a complex according to claim 1, wherein
the step (a) comprises:
bringing the sample containing the target into contact with the label molecule A, the label molecule B, the label molecule C, and a label molecule D; and
forming the complex comprising the target, the label molecule A, the label molecule B, the label molecule C, and the label molecule D,
the label molecule D has a nucleic acid sequence capable of hybridizing to a part of the label molecule B and substantially complementary to the nucleic acid sequence of the label molecule B, and
at least one of either the label molecule B or the label molecule D has at least one of either magnetic microparticles or metal microparticles.

### Claim 4 (depends on 1)

The method for producing a complex according to claim 1, wherein
the label molecule A has an x region, a y region, and a z region,
the label molecule C has an X region and a Y region,
the x region is a nucleic acid sequence substantially complementary to a nucleic acid sequence of the X region,
the y region is a nucleic acid sequence substantially complementary to a nucleic acid sequence of the Y region, and
the z region is a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target.

### Claim 5 (depends on 4)

The method for producing a complex according to claim 4, wherein
the label molecule A has two or more of at least either x regions or y regions in a molecule of the label molecule A and the label molecule C has an X region and a Y region in a molecule of the label molecule C,
the label molecule C has two or more of at least either X regions or Y regions in a molecule of the label molecule C and the label molecule A has an x region and a y region in a molecule of the label molecule A, or
the label molecule A has two or more of at least either x regions or y regions in a molecule of the label molecule A and the label molecule C has two or more of at least either X regions and Y regions in a molecule of the label molecule C.

### Claim 6 (depends on 3)

The method for producing a complex according to claim 3, wherein
the label molecule B has a u region, a v region, and a w region,
the label molecule D has a U region and a V region,
the u region is a nucleic acid sequence substantially complementary to a nucleic acid sequence of the U region,
the v region is a nucleic acid sequence substantially complementary to a nucleic acid sequence of the V region, and
the w region is a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target.

### Claim 7 (depends on 6)

The method for producing a complex according to claim 6, wherein
the label molecule B has two or more of at least either u regions or v regions in a molecule of the label molecule B and the label molecule D has an U region and a V region in a molecule of the label molecule D,
the label molecule D has two or more of at least either U regions or V regions in a molecule of the label molecule D and the label molecule B has an u region and a v region in a molecule of the label molecule B, or
the label molecule B has two or more of at least either u regions or v regions in a molecule of the label molecule B and the label molecule D has two or more of at least either U regions or V regions in a molecule of the label molecule D.

### Claim 8

A method for determining microbial inclusion in a test object comprising:
a step (1) of obtaining a sample by treatment of a test object under conditions in which a nucleic acid derived from a microorganism is extracted when the test object includes the microorganism;
a step (2) of bringing a sample into contact with a label molecule A, a label molecule B, and a label molecule C and, when the sample contains a nucleic acid derived from the microorganism, forming a complex comprising a target, the label molecule A, the label molecule B, and the label molecule C; and
a step (3) of isolating the complex when the complex is formed,
wherein
the target is a nucleic acid derived from the microorganism,
the label molecule A comprises a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to a nucleic acid sequence of the target,
the label molecule B comprises the nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target,
a substantially complementary nucleic acid sequence of the label molecule A is capable of hybridizing to a part of the target and a substantially complementary nucleic acid sequence of the label molecule B is capable of hybridizing to another part of the target,
the label molecule C comprises a nucleic acid sequence capable of hybridizing to a part of the label molecule A and substantially complementary to the nucleic acid sequence of the label molecule A, and
at least one of either the label molecule A or the label molecule C has a phosphor.

### Claim 9 (depends on 8)

The method for determining microbial inclusion according to claim 8, wherein the label molecule B has at least one of either magnetic microparticles or metal microparticles.

### Claim 10 (depends on 8)

The method for determining microbial inclusion according to claim 8, wherein
the step (2) comprises:
bringing the sample into contact with the label molecule A, the label molecule B, the label molecule C, and a label molecule D; and
when the sample contains the nucleic acid derived from the microorganism, forming a complex comprising the target, the label molecule A, the label molecule B, the label molecule C, and the label molecule D,
the label molecule D has a nucleic acid sequence capable of hybridizing to a part of the label molecule B and substantially complementary to the nucleic acid sequence of the label molecule B, and
at least one of either the label molecule B or the label molecule D has at least one of either magnetic microparticles or metal microparticles.

### Claim 11 (depends on 8)

The method for determining microbial inclusion according to claim 8, wherein the step (1) comprises:
a step of introducing the test object into a container;
a step of hermetically sealing the container; and
a step of heating the test object hermetically sealed in the container to 100° C. or higher in a hermetically sealed state.

### Claim 12

A method for identifying a microorganism included in a test object comprising:
a step (2) of bringing a sample derived from the test object into contact with a label molecule A, a label molecule B, and a label molecule C and, when the sample contains a nucleic acid derived from the microorganism, forming a complex comprising a target, the label molecule A, the label molecule B, and the label molecule C;
a step (3) of isolating the complex when the complex is formed; and
a step (4) of identifying the microorganism from which a nucleic acid sequence of the target contained in the complex is derived,
wherein
the target is a nucleic acid derived from the microorganism,
the label molecule A comprises a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target,
the label molecule B comprises a nucleic acid sequence capable of hybridizing to a part of the target and substantially complementary to the nucleic acid sequence of the target,
a substantially complementary nucleic acid sequence of the label molecule A is capable of hybridizing to a part of the target and a substantially complementary nucleic acid sequence of the label molecule B is capable of hybridizing to another part of the target,
the label molecule C comprises a nucleic acid sequence capable of hybridizing to a part of the label molecule A and substantially complementary to the nucleic acid sequence of the label molecule A, and
at least one of either the label molecule A or the label molecule C has a phosphor.

### Claim 13 (depends on 12)

The method for identifying the included microorganism according to claim 12, wherein the label molecule B has at least one of either magnetic microparticles or metal microparticles.

### Claim 14 (depends on 12)

The method for identifying the included microorganism according to claim 12, wherein the step (2) comprises:
bringing a sample derived from a test object into contact with the label molecule A, the label molecule B, the label molecule C, and a label molecule D; and
when the sample contains a nucleic acid derived from the microorganism, forming a complex comprising the target, the label molecule A, the label molecule B, the label molecule C, and the label molecule D,
the label molecule D has a nucleic acid sequence capable of hybridizing to a part of the label molecule B and substantially complementary to the nucleic acid sequence of the label molecule B, and
at least one of either the label molecule B or the label molecule D has at least one of either magnetic microparticles or metal microparticles.

### Claim 15 (depends on 12)

The method for identifying the included microorganism according to claim 12, comprising, before the step (2):
a step (1) of obtaining a sample by treatment of the test object under conditions in which the nucleic acid derived from the microorganism is extracted when the test object includes the microorganism.
